NCT07211880 2025-10-08
Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study
Zero Helicobacter IGAN Network
Phase NA Completed
Clinical Trials
7 trialsNCT07076914 2025-07-22
PPI-PROTECT
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Not yet recruiting
NCT04697186 2023-01-31
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT02747797 2018-08-02
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations
University of California, San Diego
Phase 2 Withdrawn
NCT02449941 2016-12-06
Helicobacter Pylori and Proton Pump Inhibitor
Asan Medical Center
Completed
NCT02149914 2014-11-20
The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
Taichung Tzu Chi Hospital
Phase NA Unknown
NCT00844675 2012-10-18
Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection
The Catholic University of Korea
Phase 4 Completed